nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—MAOB—embryo—malignant glioma	0.0061	0.0691	CbGeAlD
Nandrolone decanoate—MAOB—brainstem—malignant glioma	0.00559	0.0633	CbGeAlD
Nandrolone decanoate—MAOA—embryo—malignant glioma	0.00521	0.059	CbGeAlD
Nandrolone decanoate—MAOB—telencephalon—malignant glioma	0.00496	0.0562	CbGeAlD
Nandrolone decanoate—MAOA—brainstem—malignant glioma	0.00477	0.054	CbGeAlD
Nandrolone decanoate—AR—telencephalon—malignant glioma	0.00467	0.0529	CbGeAlD
Nandrolone decanoate—MAOA—retina—malignant glioma	0.0046	0.0521	CbGeAlD
Nandrolone decanoate—MAOA—telencephalon—malignant glioma	0.00423	0.0479	CbGeAlD
Nandrolone decanoate—MAOB—Biological oxidations—GSTT1—malignant glioma	0.004	0.00439	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—RAF1—malignant glioma	0.004	0.00438	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00397	0.00435	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.0039	0.00428	CbGpPWpGaD
Nandrolone decanoate—MAOB—medulla oblongata—malignant glioma	0.0039	0.0442	CbGeAlD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—NOTCH1—malignant glioma	0.00388	0.00426	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.00383	0.0042	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—PTGS1—malignant glioma	0.00375	0.00411	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00366	0.00402	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP2B6—malignant glioma	0.00358	0.00393	CbGpPWpGaD
Nandrolone decanoate—MAOB—midbrain—malignant glioma	0.00356	0.0404	CbGeAlD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00354	0.00388	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.0035	0.00384	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP2B6—malignant glioma	0.00349	0.00383	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00349	0.00383	CbGpPWpGaD
Nandrolone decanoate—MAOB—spinal cord—malignant glioma	0.00348	0.0394	CbGeAlD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.00346	0.0038	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00344	0.00378	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00343	0.00377	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—NF1—malignant glioma	0.00336	0.00368	CbGpPWpGaD
Nandrolone decanoate—MAOA—medulla oblongata—malignant glioma	0.00333	0.0377	CbGeAlD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00331	0.00363	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PLK1—malignant glioma	0.00329	0.00361	CbGpPWpGaD
Nandrolone decanoate—AR—spinal cord—malignant glioma	0.00327	0.037	CbGeAlD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00323	0.00355	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00323	0.00354	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00317	0.00348	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—PTK2—malignant glioma	0.00314	0.00345	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00312	0.00342	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP2C18—malignant glioma	0.0031	0.0034	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—NCOR1—malignant glioma	0.00307	0.00337	CbGpPWpGaD
Nandrolone decanoate—MAOA—midbrain—malignant glioma	0.00304	0.0344	CbGeAlD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP2C18—malignant glioma	0.00303	0.00332	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00301	0.0033	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—central nervous system—malignant glioma	0.003	0.0339	CbGeAlD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00298	0.00327	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—malignant glioma	0.00298	0.00327	CbGpPWpGaD
Nandrolone decanoate—MAOA—spinal cord—malignant glioma	0.00297	0.0336	CbGeAlD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—malignant glioma	0.00295	0.00323	CbGpPWpGaD
Nandrolone decanoate—MAOB—central nervous system—malignant glioma	0.00282	0.0319	CbGeAlD
Nandrolone decanoate—MAOB—Metabolism—RTEL1—malignant glioma	0.0028	0.00307	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PML—malignant glioma	0.00278	0.00305	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—GSTP1—malignant glioma	0.00277	0.00304	CbGpPWpGaD
Nandrolone decanoate—MAOB—cerebellum—malignant glioma	0.00276	0.0312	CbGeAlD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00275	0.00302	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00275	0.00302	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.00272	0.00298	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00268	0.00294	CbGpPWpGaD
Nandrolone decanoate—AR—central nervous system—malignant glioma	0.00265	0.03	CbGeAlD
Nandrolone decanoate—CYP19A1—Tryptophan metabolism—MDM2—malignant glioma	0.00262	0.00287	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTT1—malignant glioma	0.00251	0.00275	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—CDKN2A—malignant glioma	0.0025	0.00275	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—CAV1—malignant glioma	0.0025	0.00274	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—malignant glioma	0.00248	0.00272	CbGpPWpGaD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—PIK3CA—malignant glioma	0.00248	0.00271	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00245	0.00269	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTT1—malignant glioma	0.00245	0.00268	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00243	0.00266	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00243	0.00266	CbGpPWpGaD
Nandrolone decanoate—MAOA—central nervous system—malignant glioma	0.00241	0.0273	CbGeAlD
Nandrolone decanoate—CYP19A1—brain—malignant glioma	0.00238	0.0269	CbGeAlD
Nandrolone decanoate—MAOA—cerebellum—malignant glioma	0.00235	0.0266	CbGeAlD
Nandrolone decanoate—MAOA—Biological oxidations—PTGS1—malignant glioma	0.00235	0.00258	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—PTGS1—malignant glioma	0.00229	0.00252	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00226	0.00248	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—STAT3—malignant glioma	0.00225	0.00247	CbGpPWpGaD
Nandrolone decanoate—MAOB—brain—malignant glioma	0.00224	0.0254	CbGeAlD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—malignant glioma	0.0022	0.00241	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00214	0.00235	CbGpPWpGaD
Nandrolone decanoate—AR—brain—malignant glioma	0.00211	0.0239	CbGeAlD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—AKT1—malignant glioma	0.00202	0.00222	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—malignant glioma	0.00202	0.00221	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00199	0.00219	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00197	0.00216	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—AKT1—malignant glioma	0.00194	0.00213	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00194	0.00213	CbGpPWpGaD
Nandrolone decanoate—MAOA—brain—malignant glioma	0.00191	0.0216	CbGeAlD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00191	0.00209	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—malignant glioma	0.00184	0.00202	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—malignant glioma	0.00183	0.002	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00182	0.002	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—MDM2—malignant glioma	0.00179	0.00197	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00177	0.00194	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—RTEL1—malignant glioma	0.00176	0.00193	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00176	0.00193	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTP1—malignant glioma	0.00174	0.00191	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00174	0.00191	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—RTEL1—malignant glioma	0.00172	0.00188	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTP1—malignant glioma	0.0017	0.00186	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTP1—malignant glioma	0.00167	0.00184	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—malignant glioma	0.00165	0.00181	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00165	0.00181	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—COX8A—malignant glioma	0.00161	0.00177	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.0016	0.00175	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.00154	0.00169	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—PTEN—malignant glioma	0.00151	0.00166	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BCHE—malignant glioma	0.00148	0.00163	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00146	0.0016	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00143	0.00156	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.0014	0.00154	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—SLC6A3—malignant glioma	0.0014	0.00153	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ASMT—malignant glioma	0.00137	0.0015	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—malignant glioma	0.00137	0.0015	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.00135	0.00148	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—STAT3—malignant glioma	0.00135	0.00148	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.00133	0.00146	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BCAN—malignant glioma	0.00129	0.00141	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00128	0.0014	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00124	0.00136	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—EGFR—malignant glioma	0.00123	0.00135	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00123	0.00134	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00122	0.00134	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.00121	0.00132	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.00119	0.00131	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00119	0.0013	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—AKT1—malignant glioma	0.00118	0.00129	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.00118	0.00129	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00113	0.00124	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.00107	0.00117	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.00105	0.00115	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00104	0.00114	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—IDH2—malignant glioma	0.00104	0.00114	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.00103	0.00113	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.00103	0.00113	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.00103	0.00112	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH2—malignant glioma	0.00102	0.00111	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.00101	0.00111	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—COX8A—malignant glioma	0.00101	0.00111	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000989	0.00108	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000989	0.00108	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000989	0.00108	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—COX8A—malignant glioma	0.000985	0.00108	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2B6—malignant glioma	0.000975	0.00107	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000974	0.00107	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000971	0.00107	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000961	0.00105	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000945	0.00104	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000939	0.00103	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000938	0.00103	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000906	0.000994	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000905	0.000993	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000904	0.000992	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000893	0.000979	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—IDH1—malignant glioma	0.000892	0.000978	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000881	0.000966	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000873	0.000957	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000872	0.000956	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00087	0.000954	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—AKT1—malignant glioma	0.00087	0.000954	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SPHK1—malignant glioma	0.000863	0.000947	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ASMT—malignant glioma	0.000859	0.000942	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000851	0.000933	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP2C18—malignant glioma	0.000846	0.000928	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ASMT—malignant glioma	0.000838	0.000919	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000828	0.000909	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NCOR1—malignant glioma	0.000828	0.000908	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000826	0.000906	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000822	0.000901	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000819	0.000899	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000819	0.000898	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BCAN—malignant glioma	0.000808	0.000886	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000804	0.000881	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BCAN—malignant glioma	0.000788	0.000864	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—DNMT3B—malignant glioma	0.000774	0.000848	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000768	0.000843	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000767	0.000842	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000759	0.000833	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BRAF—malignant glioma	0.000758	0.000831	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HIST1H3B—malignant glioma	0.000751	0.000824	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000746	0.000818	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00074	0.000812	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000707	0.000775	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000691	0.000758	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTT1—malignant glioma	0.000684	0.00075	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000681	0.000747	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000675	0.00074	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000666	0.00073	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000658	0.000721	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000653	0.000716	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—IDH2—malignant glioma	0.000651	0.000714	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS1—malignant glioma	0.000641	0.000703	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—IDH2—malignant glioma	0.000635	0.000696	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—MDM2—malignant glioma	0.000635	0.000696	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000634	0.000696	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—RAF1—malignant glioma	0.000633	0.000694	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000629	0.00069	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000628	0.000689	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2B6—malignant glioma	0.000612	0.000671	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000599	0.000657	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2B6—malignant glioma	0.000597	0.000655	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BCHE—malignant glioma	0.000596	0.000654	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—PPARG—malignant glioma	0.000593	0.000651	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC5A5—malignant glioma	0.000589	0.000646	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000581	0.000637	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—H3F3A—malignant glioma	0.00058	0.000637	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000578	0.000634	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.00057	0.000625	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—IDH1—malignant glioma	0.00056	0.000614	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000559	0.000613	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—IDH1—malignant glioma	0.000546	0.000599	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH3—malignant glioma	0.000545	0.000598	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SPHK1—malignant glioma	0.000542	0.000594	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP2C18—malignant glioma	0.000531	0.000582	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SPHK1—malignant glioma	0.000528	0.000579	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP2C18—malignant glioma	0.000518	0.000568	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.00049	0.000538	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH2—malignant glioma	0.000489	0.000536	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000488	0.000535	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTP1—malignant glioma	0.000474	0.00052	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000472	0.000518	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CAT—malignant glioma	0.000461	0.000506	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000445	0.000488	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOR1—malignant glioma	0.000436	0.000478	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTT1—malignant glioma	0.000429	0.000471	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000429	0.000471	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—CDKN2B—malignant glioma	0.00042	0.000461	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTT1—malignant glioma	0.000419	0.000459	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS1—malignant glioma	0.000402	0.000441	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NCOR1—malignant glioma	0.000398	0.000437	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS1—malignant glioma	0.000392	0.00043	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000391	0.000429	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BCHE—malignant glioma	0.000374	0.00041	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC5A5—malignant glioma	0.000369	0.000405	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BCHE—malignant glioma	0.000365	0.0004	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC5A5—malignant glioma	0.00036	0.000395	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CAV1—malignant glioma	0.000355	0.00039	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000341	0.000374	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—malignant glioma	0.000338	0.000371	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000338	0.00037	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CG—malignant glioma	0.000323	0.000355	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PPARG—malignant glioma	0.000312	0.000342	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH1—malignant glioma	0.000303	0.000332	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTP1—malignant glioma	0.000297	0.000326	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000294	0.000323	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTP1—malignant glioma	0.00029	0.000318	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CAT—malignant glioma	0.000289	0.000317	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PPARG—malignant glioma	0.000286	0.000313	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CD—malignant glioma	0.000284	0.000312	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CAT—malignant glioma	0.000282	0.00031	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOR1—malignant glioma	0.000273	0.0003	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOR1—malignant glioma	0.000267	0.000292	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CB—malignant glioma	0.000248	0.000272	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—malignant glioma	0.000246	0.000269	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CAV1—malignant glioma	0.000223	0.000244	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CAV1—malignant glioma	0.000217	0.000238	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTEN—malignant glioma	0.000214	0.000235	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000208	0.000228	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CG—malignant glioma	0.000203	0.000223	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CG—malignant glioma	0.000198	0.000217	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PPARG—malignant glioma	0.000196	0.000215	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PPARG—malignant glioma	0.000191	0.00021	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CD—malignant glioma	0.000178	0.000196	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CD—malignant glioma	0.000174	0.000191	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—malignant glioma	0.000163	0.000179	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CB—malignant glioma	0.000156	0.000171	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—malignant glioma	0.000154	0.000169	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CB—malignant glioma	0.000152	0.000166	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CA—malignant glioma	0.000151	0.000166	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—malignant glioma	0.00015	0.000165	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTEN—malignant glioma	0.000134	0.000147	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTEN—malignant glioma	0.000131	0.000144	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—malignant glioma	0.000123	0.000135	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—malignant glioma	0.000113	0.000124	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CA—malignant glioma	9.48e-05	0.000104	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CA—malignant glioma	9.25e-05	0.000101	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—malignant glioma	7.75e-05	8.5e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—malignant glioma	7.55e-05	8.29e-05	CbGpPWpGaD
